Who are Drug: BufferGel® with diaphragm's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/drug-buffergel-with-diaphragm.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Drug: BufferGel® with diaphragm — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drug: BufferGel® with diaphragm (Drug: BufferGel® with diaphragm) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vaginal microbicide. Area: Infectious Disease / Sexual Health.

phase 2 Vaginal microbicide Infectious Disease / Sexual Health Small molecule Live · refreshed every 30 min

Target snapshot

Drug: BufferGel® with diaphragm (Drug: BufferGel® with diaphragm) — ReProtect Inc. BufferGel is a vaginal microbicide gel that buffers vaginal pH to create an acidic environment hostile to HIV and other sexually transmitted pathogens, used in conjunction with a diaphragm for contraceptive and prophylactic protection.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Drug: BufferGel® with diaphragm TARGET	Drug: BufferGel® with diaphragm	ReProtect Inc	phase 2	Vaginal microbicide

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vaginal microbicide class)

ReProtect Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Drug: BufferGel® with diaphragm — Competitive Intelligence Brief. https://druglandscape.com/ci/drug-buffergel-with-diaphragm. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab